Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys

The vaccine S-268019-b is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S)-protein vaccine consisting of full-length recombinant SARS-CoV-2 S-protein (S-910823) as antigen, mixed with the squalene-based adjuvant A-910823. The current study evaluated the immunogenicity of S-26...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Masayuki, Nagata, Noriyo, Homma, Tomoyuki, Maeda, Hiroki, Dohi, Keiji, Seki, Naomi M., Yoshihara, Ken, Iwata-Yoshikawa, Naoko, Shiwa-Sudo, Nozomi, Sakai, Yusuke, Shirakura, Masayuki, Kishida, Noriko, Arita, Tomoko, Suzuki, Yasushi, Watanabe, Shinji, Asanuma, Hideki, Sonoyama, Takuhiro, Suzuki, Tadaki, Omoto, Shinya, Hasegawa, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167832/
https://www.ncbi.nlm.nih.gov/pubmed/35691872
http://dx.doi.org/10.1016/j.vaccine.2022.05.081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167832/
https://www.ncbi.nlm.nih.gov/pubmed/35691872
http://dx.doi.org/10.1016/j.vaccine.2022.05.081

Ejemplares similares